IDH3A and cancer: According to the 5th revision of World Health Organization (WHO) of central nervous system tumors classification, gliosarcoma is a malignant tumor grade 4 and is the rarest and aggressive subtype of isocitrate dehydrogenase (IDH) wild-type glioblastoma.